Targeting chemoresistant senescent pancreatic cancer cells improves conventional treatment efficacy

Pancreatic cancer is one of the deadliest cancers owing to its late diagnosis and of the strong resistance to available treatments. Despite a better understanding of the disease in the last two decades, no significant improvement in patient care has been made. Senescent cells are characterized by a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaber, Sara, Warnier, Marine, Leers, Christopher, Vernier, Mathieu, Goehrig, Delphine, Médard, Jean-Jacques, Vindrieux, David, Ziegler, Dorian V., Bernard, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899302/
https://www.ncbi.nlm.nih.gov/pubmed/36739330
http://dx.doi.org/10.1186/s43556-023-00116-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899302/
https://www.ncbi.nlm.nih.gov/pubmed/36739330
http://dx.doi.org/10.1186/s43556-023-00116-4

Ejemplares similares